1BQ

[4-(2-hydroxyethyl)piperidin-1-yl][4-(5-methyl-4,4-dioxido-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-yl)phenyl]methanone

Created:	2012-11-28
Last modified:	2013-03-06

Find Related PDB Entry
1 entries where 1BQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	0
Bond Count	63
Aromatic Bond Count	17

2D diagram of 1BQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[4-(2-hydroxyethyl)piperidin-1-yl][4-(5-methyl-4,4-dioxido-1,5-dihydropyrazolo[4,3-c][2,1]benzothiazin-8-yl)phenyl]methanone
Systematic Name (OpenEye OEToolkits)	[4-(2-hydroxyethyl)piperidin-1-yl]-[4-[5-methyl-4,4-bis(oxidanylidene)-1H-pyrazolo[4,3-c][2,1]benzothiazin-8-yl]phenyl]methanone
Formula	C₂₄ H₂₆ N₄ O₄ S
Molecular Weight	466.553
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N1CCC(CCO)CC1)c2ccc(cc2)c5cc4c3c(cnn3)S(=O)(=O)N(c4cc5)C
SMILES	CACTVS	3.370	CN1c2ccc(cc2c3[nH]ncc3[S]1(=O)=O)c4ccc(cc4)C(=O)N5CCC(CCO)CC5
SMILES	OpenEye OEToolkits	1.7.6	CN1c2ccc(cc2-c3c(cn[nH]3)S1(=O)=O)c4ccc(cc4)C(=O)N5CCC(CC5)CCO
Canonical SMILES	CACTVS	3.370	CN1c2ccc(cc2c3[nH]ncc3[S]1(=O)=O)c4ccc(cc4)C(=O)N5CCC(CCO)CC5
Canonical SMILES	OpenEye OEToolkits	1.7.6	CN1c2ccc(cc2-c3c(cn[nH]3)S1(=O)=O)c4ccc(cc4)C(=O)N5CCC(CC5)CCO
InChI	InChI	1.03	InChI=1S/C24H26N4O4S/c1-27-21-7-6-19(14-20(21)23-22(15-25-26-23)33(27,31)32)17-2-4-18(5-3-17)24(30)28-11-8-16(9-12-28)10-13-29/h2-7,14-16,29H,8-13H2,1H3,(H,25,26)
InChIKey	InChI	1.03	FADYFQASOSLUAS-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	70789288
ChEMBL	CHEMBL2333434

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.